Results 191 to 200 of about 436,688 (335)

A rare case of hepatoid adenocarcinoma of the lung initially presenting as a painful skin nodule. [PDF]

J Surg Case Rep
Khabbaza R, Shawish A, Mahmoud A, Houreih MA, Al-Janabi MH, Hassan F.   +5 more
europepmc   +1 more source

Primary clear cell adenocarcinoma of the lung: a national analysis. [PDF]

J Thorac Dis, 2023
Mansur A, Saleem Z, Potter AL, Mathey-Andrews C, Senthil P, Yang CJ.   +5 more
europepmc   +1 more source

Mucinous (Colloid) Adenocarcinoma of the Lung

Archives of Pathology & Laboratory Medicine, 2005
Noel A, Brownlee, Ryan T, Mott, Annabelle, Mahar, Victor L, Roggli   +3 more
openaire   +2 more sources

IL4I1⁺ Macrophages and TDO2⁺ Myofibroblasts Drive AhR‐Mediated Immunosuppression and Ferroptosis Resistance in Solid Predominant Lung Adenocarcinoma

Advanced Science, EarlyView.
Solid predominant lung adenocarcinoma exhibits an immune‐excluded, ferroptosis‐resistant niche enriched with IL4I1⁺ TAMs and TDO2⁺ myCAFs. Spatial and multi‐omics analyses reveal AhR‐driven crosstalk that promotes T cell exhaustion and therapy resistance. Blocking AhR with CH‐223191 restores ferroptosis sensitivity, and its combination with ferroptosis
Zhaoxuan Wang, Weijiao Xu, Lei Zhao, Lin Zhong, Wendan Yu, Shengmin Wang, Lu Sun, Tao Guo, Fengzhou Li, Zhuoshi Li, Lei Fang, Shiqing Wang, Guohui Zhang, Guoqing Xue, Wei Guo, Shilei Zhao, Chundong Gu   +16 more
wiley   +1 more source

Colloid Adenocarcinoma of the Lung: A Rare and Unique Entity. [PDF]

Cureus
Bhatta U, Lopez-Calderon L.
europepmc   +1 more source

HSP70 Interactome‐Mediated Proteolysis Targeting Chimera (HSP70‐PROTAC) for Ferroptosis‐Driven Cancer Treatment

Advanced Science, EarlyView.
This study reports a novel targeted protein degradation strategy termed “HSP70‐PROTAC” that recruits Hsc70 complex to a target protein for inducing degradation. Among them, GDAz‐3 exhibits effective GPX4 degradation activity via UPS/CMA processes, triggering ferroptosis‐driven anticancer activity in vitro and in vivo.
Jinyun Dong, Yulong Li, Hui Liang, Zumei Wu, Shiqun Wang, Yichao Wang, Jieyu Xu, Yanning Lan, Maohua Cai, Guangzhao Pan, Haiyan Yang, Kai Miao, Zhe‐Sheng Chen, Fangfang Tao, Xuelei Ma, Jiang‐Jiang Qin   +15 more
wiley   +1 more source

Lucky case of pinch-off syndrome combined with colloid adenocarcinoma of the lung. [PDF]

J Surg Case Rep
Jeong J, Kang MK, Kim JY.
europepmc   +1 more source

Mucinous Adenocarcinoma of the Lung: A Great Mimicker of Pneumonia. [PDF]

Cureus, 2023
Cabrera Charleston M, Lizarraga Madrigal D, Khan A, Eapen G, Grosu H.   +4 more
europepmc   +1 more source

A Natural Sweetener‐inducible Genetic Switch Controls Therapeutic Protein Expression in Mammals

Advanced Science, EarlyView.
This study develops a natural sweetener, the psicose‐inducible transgene expression (PURE) system based on an Agrobacterium tumefaciens–derived transcriptional repressor PsiR. The PURE system is highly specific to psicose, being insensitive to other sugars and structurally similar molecules.
Longliang Qiao, Zhihao Wang, Shasha Tang, Yuan Fang, Guiling Yu, Xiaoting Qiu, Lingxue Niu, Tao Yan, Xingwan Liu, Xiaoding Ma, Deqiang Kong, Yang Zhou, Ningzi Guan, Jinzhong Tian, Meiyan Wang, Haifeng Ye, Fengfeng Cai   +16 more
wiley   +1 more source

Moving Through Genetic Alterations and PD-L1 Expression in High-Grade Fetal Adenocarcinoma of the Lung: A Case Report and Literature Review. [PDF]

Int Med Case Rep J
Xu Y, Dai K, Chen W, Wu H, Lin P.
europepmc   +1 more source